FRM
Fox Run Management’s Novartis NVS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-17,840
| Closed | -$1.99M | – | 1111 |
|
2025
Q1 | $1.99M | Buy |
17,840
+3,351
| +23% | +$374K | 0.31% | 29 |
|
2024
Q4 | $1.41M | Sell |
14,489
-158
| -1% | -$15.4K | 0.26% | 67 |
|
2024
Q3 | $1.68M | Buy |
14,647
+12,156
| +488% | +$1.4M | 0.37% | 11 |
|
2024
Q2 | $265K | Buy |
+2,491
| New | +$265K | 0.05% | 582 |
|
2023
Q3 | – | Sell |
-5,915
| Closed | -$597K | – | 901 |
|
2023
Q2 | $597K | Buy |
+5,915
| New | +$597K | 0.17% | 237 |
|
2023
Q1 | – | Sell |
-3,572
| Closed | -$324K | – | 847 |
|
2022
Q4 | $324K | Sell |
3,572
-5,694
| -61% | -$517K | 0.13% | 313 |
|
2022
Q3 | $704K | Buy |
9,266
+1,880
| +25% | +$143K | 0.27% | 76 |
|
2022
Q2 | $624K | Buy |
+7,386
| New | +$624K | 0.31% | 67 |
|
2021
Q3 | – | Sell |
-3,920
| Closed | -$358K | – | 574 |
|
2021
Q2 | $358K | Buy |
+3,920
| New | +$358K | 0.33% | 115 |
|
2020
Q3 | – | Sell |
-2,385
| Closed | -$208K | – | 275 |
|
2020
Q2 | $208K | Buy |
+2,385
| New | +$208K | 0.28% | 203 |
|
2019
Q4 | – | Sell |
-5,316
| Closed | -$462K | – | 485 |
|
2019
Q3 | $462K | Buy |
+5,316
| New | +$462K | 0.42% | 49 |
|
2019
Q1 | – | Sell |
-6,219
| Closed | -$534K | – | 628 |
|
2018
Q4 | $534K | Sell |
6,219
-375
| -6% | -$32.2K | 0.28% | 90 |
|
2018
Q3 | $568K | Buy |
+6,594
| New | +$568K | 0.25% | 136 |
|
2017
Q4 | – | Sell |
-4,400
| Closed | -$378K | – | 815 |
|
2017
Q3 | $378K | Sell |
4,400
-300
| -6% | -$25.8K | 0.11% | 400 |
|
2017
Q2 | $392K | Buy |
+4,700
| New | +$392K | 0.14% | 318 |
|
2016
Q4 | – | Sell |
-3,800
| Closed | -$300K | – | 619 |
|
2016
Q3 | $300K | Sell |
3,800
-2,300
| -38% | -$182K | 0.18% | 247 |
|
2016
Q2 | $503K | Buy |
6,100
+2,100
| +53% | +$173K | 0.24% | 124 |
|
2016
Q1 | $290K | Buy |
+4,000
| New | +$290K | 0.19% | 236 |
|